Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Oncology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain Management/
    Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
brca1  brca1
prostate-specific antigen  prostate-specific antigen
sclc  sclc
fobt  fobt
egd  egd
bmi  bmi
dysplasia  dysplasia
hematologic  hematologic
ovarian  ovarian
hcc  hcc
 
Sponsor

Your Unread Messages

Medicare Final Rule for 2010
Roberta Buell, MBA, Sausalito Healthcare Partners
Cancer Science: Using Embryonic Stem Cells to Test Breast Cancer Genes
Sara Hartley, MDLinx Oncology
Technology Advances: Nanotech PSA Levels Unmask Lingering Prostate Cancer
Dorothy J. Schirf, MD, MDLinx Oncology
  See all

Articles: Gynecologic Oncology



Latest (7) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study
Cancer Causes and Control, 10/02/09
Sponsor
Ranked importance of outcomes of first-line versus repeated chemotherapy among ovarian cancer patients
Supportive Care in Cancer, 10/01/09
Effects of Lewis Y antigen on the gene expression of multiple drug resistance-associated proteins in human ovarian cancer RMG-I-H cells
Medical Oncology, 10/01/09
p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women
Medical Oncology, 10/01/09
Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: Therapeutic potential for ovarian cancer
Cancer Science, 09/30/09
Pegylated liposomal doxorubicin combined with carboplatin: A rational treatment choice for advanced ovarian cancer
Critical Reviews in Oncology/Hematology, 09/30/09
The importance of precise pT diagnosis for prognostic prediction of uterine cervical cancer—a single institutional report at a Japanese comprehensive cancer hospital
Virchows Archiv, 09/30/09
Exclusive Author Commentary
Breastfeeding and risk of epithelial ovarian cancer
Cancer Causes and Control, 09/29/09
Ovarian cancer survival population differences: a high resolution study comparing Philippine residents, and Filipino-Americans and Caucasians living in the US
BMC Cancer, 09/29/09    Free full text
Sensitization of ovarian carcinoma cells to the atypical retinoid ST1926 by the histone deacetylase inhibitor, RC307: Enhanced DNA damage response
International Journal of Cancer, 09/29/09
Bcl-xL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis
International Journal of Cancer, 09/29/09
Co-expression of survivin, c-erbB2, and cyclooxygenase-2 (COX-2): prognostic value and survival of endometrial cancer patients
Journal of Cancer Research & Clinical Oncology, 09/28/09
Characterization of endoglin and Ki-67 expression in endothelial cells from benign and malignant lesions of the uterine cervix
Pathology International, 09/28/09
Tea consumption and risk of endometrial cancer: a metaanalysis
American Journal of Obstetrics and Gynecology, 09/25/09
Review role of topotecan in gynaecological cancers: Current indications and perspectives
Critical Reviews in Oncology/Hematology, 09/25/09
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
The Lancet - Early Online Publication, 09/24/09
Sentinel lymph node examination for cancer of the uterine cervix
Journal of Clinical Pathology, 09/24/09
Identification of potential serum markers for endometrial cancer using protein expression profiling
Journal of Cancer Research & Clinical Oncology, 09/24/09
Incomplete pregnancy and risk of ovarian cancer: results from two Australian case–control studies and systematic review
Cancer Causes and Control, 09/24/09
The effects of polymorphisms in methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), and methionine synthase reductase (MTRR) on the risk of cervical intraepithelial neoplasia and cervical cancer in Korean women
Cancer Causes and Control, 09/24/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology more...
250 Available Pages
First    Prev    5      6      7      8      9      10      11      12      13      14      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.